Director/PDMR Shareholding
Source: RNSNotification of transactions by Persons Discharging Managerial Responsibilities ('PDMRs') and persons closely associated with them
The company has been notified by the Director and person closely associated listed below of a transaction in the Company's Ordinary shares of £0.05 each (the 'Shares').
This announcement is made in accordance with the requirements of the EU Market Abuse Regulation.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||
|
a) |
Name |
|
|||||||
|
2. |
Reason for the notification |
||||||||
|
a) |
Position/Status |
|
|||||||
|
b) |
Initial Notification/ Amendment |
Initial notification |
|||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||
|
a) |
Name |
Mid Wynd International Investment Trust PLC |
|||||||
|
b) |
LEI |
549300D32517C2M3A561 |
|||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Description : Mid Wynd International Investment Trust PLC Type : Ordinary shares ISIN : GB00B6VTTK07 |
|||||||
|
b) |
Nature of Transaction |
Acquisition of Ordinary shares of £0.05 |
|||||||
|
c) |
Price(s) and volume(s) |
|
|||||||
|
d) |
Aggregated information |
|
|||||||
|
|
- Aggregated volume
- Price |
|
|||||||
|
e) |
Date of the transaction |
17 March 2020 |
|||||||
|
f) |
Place of the transaction |
XLON |
|||||||
|
Name of authorised official of issuer responsible for making notification
Artemis Fund Managers Limited Company Secretary
0131 225 7300
17 March 2020 |
|||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
